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The role of retinoic acid (RA) in liver fibrogenesis was previously studied in cultured hepatic stellate cells (HSCs). RA suppresses the
expression of α2(I) collagen by means of the activities of specific nuclear receptors RARα, RXRβ and their coregulators. In this study, the effects
of RA in fibrogenesis were examined in carbon tetrachloride (CCl4) induced liver fibrosis in mice. Mice were treated with CCl4 or RA and CCl4,
along side control groups, for 12weeks. RA reduced the amount of histologically detectable fibrosis produced by CCl4. This was accompanied by
a attenuation of the CCl4 induced increase in α2(I) collagen mRNA and a lower (2-fold versus 3-fold) increase in liver hydroxyproline.
Furthermore, RA reduced the levels of 3-nitrotyrosine (3-NT) protein adducts and thiobarbituric acid (TBA) reactive substance (TBARS) in the
liver, which are formed as results of oxidative stress induced by CCl4 treatment. These in vivo findings support our previous in vitro studies in
cultured HSC of the inhibitory effect of RA on type I collagen expression. The data also provide evidence that RA reduces CCl4 induced oxidative
stress in liver, suggesting that the anti-fibrotic role of RA is not limited to the inhibition of type I collagen expression.
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Many factors cause liver injury that often progresses to
fibrosis. Type I collagen overexpression and deposition feature
the primary pathology of liver fibrosis leading to cirrhosis [1,2].
Type I collagen is composed of two α1 I and one α2 I collagen
polypeptide chains [3]. Hepatic stellate cells are the principal
sources of type I collagen during liver fibrogenesis [4,5]. In the
quiescent state, stellate cells store vitamin A [6,7]. Transfor-
mation of quiescent HSC to activated HSC occurs upon liver
injury of different causes. Concomitantly vitamin A storage is
diminished in activated hepatic stellate cells, as well as the
signal transduction induced by retinoic acid (RA), a potent
metabolite of vitamin A. These changes are the foundation for
investigation of the role of RA in liver fibrosis.
Retinoic acid reduces human liver stellate cell proliferation
and collagen production in culture [8,9]. Retinoic acid was⁎ Corresponding author.
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doi:10.1016/j.bbadis.2006.08.009shown to down regulate type I collagen production in activated
HSCs by suppressing the expression of α2(I) collagen [10,11].
This downregulatory effect of RA ismediated by specific nuclear
receptors RARβ and RXRα, and through their interactions with
their coregulators [11,12]. In addition, RA was shown to be
protective to oxidative stress mediated tissue injury [13,14].
Carbon tetrachloride (CCl4) induced liver injury and fibrosis
[15–18] has been widely used as a rodent model of fibrosis. The
mechanism underlying the hepatoxicity of CCl4 involves
oxidative stress initiated by CCl4-derived reactive free radical
metabolite trichloromethyl (CCl3) radicals (CCl3·) [19]. CCl3· is
biotransformed into peroxynitrite, a strong oxidant able of
disrupting physiological cellular structure and function through
peroxidation of cellular lipids, protein and DNA [20–23].
Peroxynitrite interacts with tyrosine residues to form 3-
nitrotyrosine (3-NT) protein adducts [24,25], which reflects
the peroxynitrite-mediated damage and is used as a biomarker
of peroxynitrite formation [24]. Elevation of 3-NT occurs in
chronic hepatitis and cirrhosis [26–28]. Lipid peroxidation by
peroxynitrite, on the other hand, generates thiobarbituric acid
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also an indicator of oxidative stress induced tissue injury.
In this study, we examined the effect of RA on CCl4 induced
liver fibrosis in mice, to further determine the role of RA in
suppressing liver fibrosis in vivo.
2. Materials and methods
2.1. Animals and materials
Male wild type C57BL/6J mice were purchased from Jackson Laboratory,
Bar Harbor, ME. Sirius Red was obtained from Polysciences, Inc, Warrington,
PA. Carbon tetrachloride, All-trans retinoic acid and thiobarbituric acid were
from Sigma Chemical Co., St. Louis, MO. Polyclonal rabbit-anti-3-NT antibody
was obtained from Upstate USA Inc., Lake Placid, NY.
2.2. Carbon tetrachloride and retinoic acid administrations in mice
and liver harvesting
The animal experiments were approved and conducted in accordance with
the institutional guidelines of the Animal Care and Use Committee of the Johns
Hopkins University. Male WT C57BL/6 mice 4–6weeks of age weighing
20–25gwere kept in a temperature-controlled roomwith an alternating 12-h dark
and light cycle. Four groups of mice were studied. One group of 8 mice was
treated with CCl4 alone, while another group of 8mice was treated with CCl4 and
RA. The other two groups of 4 mice each were treated with olive oil (control) or
RA alone. CCl4 was given biweekly as intraperitoneal injections in a dose of
0.5μl/gram body weight (BW) as a 20% solution. RA was also injected
intraperitoneally in a dose of 1μg/ gram BWas a 0.5μg/μl solution, three times
per week. CCl4 was dissolved in olive oil and the retinoic acid was sonicated into
olive oil. The mice of the control group were given intraperitoneal injections of
olive oil. The mice were sacrificed 12weeks after the start of the injections.
The livers were removed, rinsed with PBS, and divided into portions: (a)
fixed in 10% buffered formaldehyde formalin and embedded in paraffin; (b)Fig. 1. Histology with sirius red staining of collagen of the livers of mice treated wit
both. (original magnification ×100).snap frozen at −70 °C for hydroxyproline assay; (c) homogenized in appropriate
buffer(s) and aliquots frozen at −70 °C for biochemical assays; and (d) used
immediately for total RNA isolation.
2.3. Morphometric collagen determination
The liver sections imbedded in paraffin were cut (5μ) and stained with
hematoxylin–eosin (H&E), Masson's trichrome, or Sirius red [33]. Fibrosis was
determined histologically by measuring the intensity of fibrosis in 4–6 (×100)
digital images captured from Sirius red stained slides of each mouse liver using
MetaMorph 6.0 imaging software (Molecular Devices Co., Sunnyvale, CA). A
total fibrosis density score was determined by multiplying the integrated image
intensity with the area from which the integrated intensity was calculated.
Intensity exclusion parameters were identical for each of the images captured.
2.4. Liver hydroxyproline
Liver slices were homogenized in buffer and hydrolyzed in 12M HCl at
100 °C for 12h. After hydrolysis the pH was adjusted to pH 7.0 with 10N NaOH
and the samples were centrifuged at 750×g for 15min. The hydroxyproline
content was measured by the spectrophotometric method of Bergman and
Loxley [34].
2.5. Determination of messenger RNA by real time quantitative
polymerase chain reaction (RT-qPCR)
Total cellular RNA was isolated from a portion of liver using the Stat-60
reagent (AMS Biotechnology Ltd., Milton Abingdon, Oxon, UK), followed by
further cleaning with the use of an RNeasy kit (Qiagen, Valencia, CA). The
concentration of the isolated RNA was determined from the optical density at
260nm and its purity from the 260 nm/280 nm OD ratio. The isolated RNA is
stored at −80 °C.
To determine the quantity of mRNAs, the reverse transcription was
performed with the use of Superscript First strand synthesis kit (Invitrogen,
Carlsbad, CA ) to synthesize cDNA. Gene-transcript levels of α2 (I) collagenh (A) olive oil (control); (B) retinoic acid (RA); (C) CCl4 and (D) CCl4 and RA
Fig. 2. Effects of carbon tetrachloride and retinoic acid on hepatic fibrosis.
Collagen deposit was determined by measurement of the relative density and
area of fibrosis of 6–8 (40×) digital images captured of liver slides from each
mouse liver stained with Sirius red. A density score was determined by
multiplying the integrated image intensity with the area from which the
integrated intensity was calculated. Data are presented as means±SE of 4–
8 determinations. ⁎p<0.01 versus Control (Ctrl, no treatment); ++p<0.01 versus
CCl4 treatment alone (CCl4).
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(GAPDH) were quantified by RT-qPCR with the use of respective Taqman
gene expression assay kit (Applied Biosystems, Foster City, CA), on an ABI
HT7900 (Applied Biosystems, Foster City, CA). Variation in the amount of
transcript in different samples was corrected for by GAPDH expression.
Sequences of the primer pairs used for the PCR to identify the transcripts were
proprietary.
2.6. Immunohistochemcal detection of 3-nitrotyrosine
Liver sections (5μ) were immunostained for 3-nitrotyrosine protein adducts
with rabbit polyclonal anti-nitrotyrosine antibody (1:1000 dilution, Chemicon-
Upstate, Temecula, CA) followed by anti-rabbit secondary antibody (Rabbit
ImmunoCruz Staining system kit, Santa Cruz Biotechnology, Inc., Santa Cruz,
CA). The sections were visualized by light microscopy.
2.7. Lipid peroxidation assay
Hepatic lipid peroxidation in the mouse liver of various treatment was
determined by measuring colorimetrical changes resulted from the reaction
between thiobarbituric acid (TBA)-reactive substance (TBARS), the products of
lipid peroxidation in animal tissue, with TBA [32]. Liver tissue was
homogenized in 9vol of 50mmol/L Tris–HCl buffer (pH 7.4) containing
180mmol/L KCl, 10mmol/L EDTA, and 0.02% butylated hydroxytoluene. To
the tissue homogenate, equal volume of 8.1% sodium dodecyl sulfate,
7.5volume of 20% acetic acid, 7.5vol of 0.9% TBA, and 3vol of distilled
water were added and mixed by vortexing. The samples were then incubated in a
water bath at 95 °C for 1hour. After cooling on ice, 5vol of distilled water and
25vol of butanol/pyridine mixture (15:1, v/v) were added and vortexed. After
centrifugation at 10,000×g for 10min, absorbance of the resulting lower phase
was determined at 532nm. The TBARS concentration was calculated using
1,1,5,5-tetraethoxypropane as standard.
2.8. Statistical analysis
Data were analyzed with the Student's t test when appropriate or by two way
analysis of variance (ANOVA) when comparing means of more than two
groups.3. Results
3.1. Histomorphological characterization of effects of CCl4
and RA on liver fibrosis
The morphological changes of liver injury and fibrosis
caused by CCl4 were visualized in liver sections stained by
H&E (not shown) and Sirius red. The changes include necrosis,
inflammation with macrophages and lymphocytes, balloon cellTable 1
Influence of retinoic acid on necroinflammatory changes produced by chronic
carbon tetrachloride administration
CCl4 CCl4 +RA
Necrosis 2.2±0.21 1.9±0.26
Inflammation (zone 3) 1.8±0.18 1.9±0.25
Balloon cell change 3.6±0.19 3.0±0.26
Liver cell necrosis was evaluated on a scale of 1–4 as follows: 1, occasional; 2,
mild scattered 3, confluent zonal and 4, extensive. Scores for hepatic
inflammation were: 1, scattered; 2, mild; 3, moderate and 4, marked. Balloon
cell change was assessed as average number per 20X fields as follows: 1, 1; 2,
2–4; 3, 5–10 and 4, >10. The values are expressed as means±SE from H&E
stained slides of 8 mice per group.change and bridging fibrosis (Fig. 1C). The degrees of necrosis,
inflammation and balloon cell change were not significantly
different in animals treated with both CCL4 and RA as
compared with CCl4 alone (Table 1). Fatty infiltration was
minimal in both groups. Liver fibrosis was less evident in
mouse liver treated with both RA and CCl4 (Fig. 1D). RA
treatment alone did not cause evident changes (Fig. 1B).
3.2. Effects of RA on increase of collagen production in live
due to CCl4 treatment
The amount of fibrosis (collagen deposition) was quantified
in the liver slices stained with Sirius Red (Fig. 2). The increase
of the collagen deposition caused by CCl4 (p<0.01) was
repressed by RA treatment (p<0.01). RA alone did not cause an
evident change in liver fibrosis.
Collagen content was also determined by measurement of
hydroxyproline content in the livers (Fig. 3). The mean
hydroxyproline level was significantly higher in the CCl4Fig. 3. Liver hydroxyproline 12weeks after treatment with CCl4, RA or RA plus
CCl4. Data are presented as means±SE of 4–8 determinations. ⁎p<0.01 versus
Control (Ctrl, no treatment).
Fig. 4. Effects of carbon tetrachloride (CCl4) and retinoic acid (RA) treatments
on murine α2(I) collagen mRNA. mRNA was quantitated by real-time
quantitative PCR analysis on total RNA samples from the liver. The relative
amounts of mRNA were normalized against GADPH mRNA in the same
samples. Data are presented as means±SE of 4–8 determinations. ⁎p<0.01 vs.
Control (Ctrl, no treatment); +p<0.05 vs. CCl4 treatment alone (CCl4).
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CCl4 had a lower 2-fold increase from the control value of liver
hydroxyproline compared to the 3-fold increase in mice treated
with CCl4 alone. RA alone had no significant effect on liver
hydroxyproline.
CCl4 caused a marked increase in α2(I) collagen gene mRNA
(p<0.01) (Fig. 4). Treatment with RA significantly attenuated
the increased in the α2(I) collagen gene mRNA caused by CCl4
(p<0.05). RA alone had no effect.Fig. 5. Immunohistochemical staining of the liver sections for 3-nitrotyrosine prote
retinoic acid (RA). (A) Control, no treatment; (B) RA; (C) CCl4 and (D) CCl4 and R
with rabbit polyclonal anti-nitrotyrosine antibodies. The sections were visualized by3.3. Effect of RA in reducing CCl4 induced oxidative stress in
liver
RA (Fig. 5D) reduced the 3-nitrotyrosine (3-NT) protein
adduct immunohistochemical staining intensity in the liver
sections obtained from CCl4 treated mouse (Fig. 5C). RA also
prevented the increase of thiobarbituric acid (TBA) reactive
substance (TBARS) in the liver homogenates of the mice treated
with CCl4. The level of TBARS was 3.64±0.08 for CCl4 treat-
ment, which is significantly higher (p<0.05) than 3.03±0.26
and 3.07±0.22 for no treatment control and RA treatment alone,
respectively. The RA treatment alongside CCl4 reduced the
hepatic TBARS to 3.17±0.14 (p<0.05).
4. Discussion
This study shows that RA has an inhibitory effect on the
development of liver fibrosis in mice treated with CCl4. The
inhibition is featured in the reduced amount of type I collagen
mRNA and reduced level of type I collagen deposition in liver.
The results corroborate with and reconfirm our findings from in
vitro studies showing that RA suppresses the expression of type
I collagen in cultured HSCs [10–12]. The correlation of the in
vitro inhibitory effects of RAwith the findings in vivo validates
the future use of cultured HSCs in studying the role of RA in
liver fibrosis.
The inhibition by RA of liver fibrosis was not accompanied
by significant decrease in liver injury caused by CCl4. Priorin adducts in the livers of mice treated with carbon tetrachloride (CCl4) and/or
A both. Liver sections were immunostained for 3-nitrotyrosine protein adducts
light microscopy.
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hepatic fibrosis produced by CCl4 and pig serum in rats [35].
In other studies also in rats, administration of an RA analog
enhanced liver fibrosis produced by porcine serum [36], but
suppressed liver fibrosis produced by CCl4 [37], suggesting
that the suppressive effects of RA may involve inhibition of
the strong necroinflammatory component that accompanies the
fibrosis in the CCl4 model [38]. Liver injury produced by
CCl4 treatment is mediated by reactive oxygen species (ROS)
[39,40]. Through the CCl3· led cascade of peroxynitrite
formation, CCl4 also increases inducible nitric oxide synthase
(iNOS) [40]. Nitric oxide (NO) reacts with superoxide
yielding peroxynitrite. Tyrosine nitration is also linked to
altered protein function during inflammatory conditions, and
determination of the 3-nitrotyrosine protein adducts is
frequently used to detect oxidative damage to tissues [41].
Immunohistochemical visualization of 3-nitrotyrosine protein
adducts has been used as a biomarker of NO release and
peroxynitrite formation [42].
In this study, RA treatment reduced both the 3-NT protein
adduct formation and the level of TBARS in liver homogenates.
RA is an antioxidant and was shown to reduce enhanced ROS,
such as superoxide, in primary cultures of neonatal rat
hipoccampus treated with staurosporin [43]. RA also decreased
ROS in neutrophils of patients with promyelocytic leukemia
during treatment with N-formyl-methionyl-leucyl-phenylala-
nine [44]. RA attenuated TNF-α induced increase of iNOS in
cultured 3T3-L1 adipocytes and the accumulation of nitrite in
the culture medium [45]. Our findings and those of others
suggest that the anti-fibrogenic effects of RA are not limited to
down regulation of the type I collagen expression during repair.
Rather, the antifibrotic effects of RA begin during liver injury
and inflammation, the very initial stage of fibrogenesis.
Considering the vast spectrum of biological functions of RA,
one should not be surprised that RA is involved in the many
stages of the development of fibrosis. This finding indicates
another potential target in studying the molecular mechanism of
RA in suppressing fibrogenesis, namely the generation of free
radical and oxidative stress in liver by hepatoxic factors.
There are similarities in the mechanisms of fibrogenesis
induced by CCl4 and ethanol. Type I collagen expression in
liver is upregulated by both agents [1,11,16]. ROS formation
also mediates the liver injury caused by alcohol. Chronic
alcohol consumption is associated with sustained oxidative
stress [46,47]. However, chronic ethanol administration causes
liver injury and fibrosis only in combination with a high fat diet
[48]. Hence, knowledge of pathways of CCl4 induced liver
injury will provide information on mechanism that may also
apply to liver fibrosis in alcoholism. Indeed, oxidative stress
appears to play a important role in other etiology of liver
fibrosis, such as chronic viral hepatitis [26,46], indicating that it
is a merging pathway for various etiological forms of liver
injury and fibrogenesis.
In this study, the effects of RA in liver fibrosis were
examined in chronic liver injury caused by 12week CCl4
administration. In studies of acute liver injury, where CCl4 was
administrated for 48h or for 2weeks [49,50], greater changeswere detected in the level of indicators of oxidative stress
immediately after the cessation of the treatment. This may help
to explain the lesser changes in 3-NT protein adducts and the
TBARS content in our findings, compared to the 150% or more
increase of those observed at earlier onset of liver fibrogenesis.
Nonetheless, the reduction of TBARS content caused by RA
treatment in our study was statistically significant.
In conclusion, this study shows that RA suppresses liver
fibrogenesis through inhibitory effect on type I collagen
production in liver and through reducing liver injury caused
by oxidative stress.
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